Evidence map›Paper›PMID 39819318›Full record

SynthesisBMC gastroenterology2025

Investigating neutropenic enterocolitis: a systematic review of case reports and clinical insights.

Samane Nematolahi, Ali Amanati, Hossein Molavi Vardanjani, Mohammadreza Pourali, Mahnaz Hosseini Bensenjan, Farnoosh Nozari, Mohebat Vali, Seyed Reza Abdipour Mehrian, Seyed Ali Nabavizadeh, Farima Safari

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Epidemiology, Risk Factors, and Outcomes of Neutropenic Enterocolitis in Onco-Hematological Patients According to Chemotherapy Regimen.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  5. Article
  6. Case Report: A rare adult case ofFrontiers in immunology · 2026
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Samane NematolahiNoncommunicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran.
Ali AmanatiProfessor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. ali_amanati_1356@yahoo.com.
Hossein Molavi VardanjaniResearch Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammadreza PouraliSchool of Medicine, Bam University of Medical Sciences, Bam, Iran.
Mahnaz Hosseini BensenjanShiraz University of Medical Sciences, Shiraz, Iran.
Farnoosh NozariShiraz University of Medical Sciences, Shiraz, Iran.
Mohebat ValiDepartment of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyed Reza Abdipour MehrianClinical Research Development Center, Amir Oncology Teaching Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyed Ali NabavizadehOtolaryngology Research Center, Department of Otolaryngology, Shiraz University of Medical Sciences, Shiraz, Iran.
Farima SafariStudent Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. farimasafari40@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeutropenic enterocolitis is a serious gastrointestinal complication that can develop in patients undergoing chemotherapy or other immunosuppressive treatments. It is characterized by inflammation and necrosis of the bowel, and most commonly affects the cecum and ascending colon. Although individual case reports have described the features of NE, a comprehensive synthesis of all the published cases is required.

methodsA systematic search of the literature databases was conducted to identify all NE case reports. Data on patient demographics, clinical presentation, diagnostic findings, treatment approaches, and outcomes were independently extracted by the five reviewers. Generalized estimating equations were used to examine the associations between variables.

resultsIn total, 227 cases from 159 publications met the inclusion criteria. Most cases occur in patients with hematological cancers undergoing chemotherapy. Common presentations include abdominal pain, fever, and diarrhea. Imaging typically shows a thickening of the bowel wall. Broad-spectrum antibiotics and bowel rest were the primary initial treatment. The overall mortality rate was 33.5%. While statistical analyses did not find significant associations, factors showing clinically significant increased odds for mortality included sepsis, multiorgan failure, and isolated ileocecal valve involvement, potentially representing important prognostic indicators.

conclusionThis systematic review and meta-analysis provides the largest consolidated analysis of NE cases. It identifies typical clinical features and helps characterize risk factors and prognostic indicators to aid in the early diagnosis and management of this potentially lethal complication.

Indexed as

Enterocolitis, NeutropenicAnti-Bacterial AgentsAntineoplastic AgentsCase Reports as TopicHematologic NeoplasmsHumansMultiple Organ FailurePrognosisRisk FactorsSepsisAnti-Bacterial AgentsAntineoplastic AgentsMicrobiologyNeutropenic enterocolitisPathologyPrognosis

Identifiers

PMID39819318
PMCPMC11737258

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.